ACTIVATION OF BLOOD-COAGULATION AND FIBRINOLYSIS IN GRAVES-DISEASE

被引:29
|
作者
MARONGIU, F [1 ]
CONTI, M [1 ]
MURTAS, ML [1 ]
MAMELI, G [1 ]
SORANO, GG [1 ]
MARTINO, E [1 ]
机构
[1] UNIV CAGLIARI,CATTEDRA ENDOCRINOL,I-09100 CAGLIARI,ITALY
关键词
GRAVES DISEASE; FIBRINOGEN; FIBRINOPEPTIDE A; BLOOD COAGULATION; FIBRINOLYSIS; B-BETA-15-42;
D O I
10.1055/s-2007-1003766
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied blood coagulation and fibrinolysis activities in hyperthyroidism before and after methimazole or I-131. Fibrinopeptide A and B-beta 15-42, in vivo indicators of thrombin and plasmin activity, were measured by RIA, while fibrinogen by the Clauss method. We studied 50 patients, affected by toxic diffuse goiter. We evaluated 21 of them before and after treatment. Fibrinogen, fibrinopeptide A, and B-beta 15-42 were higher in patients than in controls (p < 0.0001). There was no difference in fibrinopeptide A nor in B-beta 15-42 before or after treatment. In euthyroidism fibrinogen returned to normal values. Inflammation of the thyroid gland secondary to autoimmunity may activate blood coagulation by release of tissue factor. High fibrinogen before treatment may be explained as an aspecific response. Since it persists in euthyroidism, autoimmunity could account for high fibrinopeptide A and B-beta 15-42 after treatment.
引用
收藏
页码:609 / 611
页数:3
相关论文
共 50 条
  • [1] BLOOD-COAGULATION AND FIBRINOLYSIS IN THYROID DISEASE
    FARID, NR
    COLLINS, JR
    MARSHALL, WH
    INGRAM, DW
    [J]. THROMBOSIS AND HAEMOSTASIS, 1976, 35 (02) : 415 - 422
  • [2] ACTIVATION OF BLOOD-COAGULATION AND FIBRINOLYSIS IN VIBRATION SYNDROME
    SHUNTO, R
    SHIRAKAMI, A
    OHARA, A
    TOIBANA, N
    SAITO, S
    [J]. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1991, 63 (04) : 293 - 296
  • [3] BLOOD-COAGULATION AND FIBRINOLYSIS
    KIENAST, J
    OSTERMANN, H
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1993, 82 : 65 - 69
  • [4] SURFACE ACTIVATION OF BLOOD-COAGULATION, FIBRINOLYSIS AND KININ FORMATION
    HEIMARK, RL
    KURACHI, K
    FUJIKAWA, K
    DAVIE, EW
    [J]. NATURE, 1980, 286 (5772) : 456 - 460
  • [5] BLOOD-COAGULATION AND FIBRINOLYSIS - AN OVERVIEW
    MOSHER, DF
    [J]. CLINICAL CARDIOLOGY, 1990, 13 (04) : 5 - 11
  • [6] DIET, BLOOD-COAGULATION AND FIBRINOLYSIS
    MARCKMANN, P
    [J]. DANISH MEDICAL BULLETIN, 1995, 42 (05) : 410 - 425
  • [7] THE PHYSIOLOGICAL INHIBITORS OF BLOOD-COAGULATION AND FIBRINOLYSIS
    STRAIGHT, DL
    [J]. JOURNAL OF MEDICAL TECHNOLOGY, 1986, 3 (08): : 443 - 446
  • [8] ABNORMALITIES OF BLOOD-COAGULATION AND FIBRINOLYSIS IN PSORIASIS
    MARONGIU, F
    SORANO, GG
    BIBBO, C
    PISTIS, MP
    CONTI, M
    MULAS, P
    BALESTRIERI, A
    BIGGIO, P
    [J]. DERMATOLOGY, 1994, 189 (01) : 32 - 37
  • [9] BLOOD-COAGULATION AND FIBRINOLYSIS IN HEMORRHAGIC STROKE
    DUBE, RK
    RAO, PVB
    SAHA, PK
    KATIYAR, BC
    DUBE, B
    [J]. THROMBOSIS AND HAEMOSTASIS, 1978, 39 (01) : 84 - 88
  • [10] INFLUENCE OF NEUROLEPTICS ON BLOOD-COAGULATION AND FIBRINOLYSIS
    GOVORIN, NV
    LOZHKINA, AN
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1991, 36 (06): : 32 - 33